World Transdermal Drug Delivery Market Reviewed in New Kelly Scientific Publications Study Available at MarketPublishers.com
26 Feb 2015 • by Natalie Aster
LONDON – The success of nicotinic patches nearly twenty years ago revolutionised the usage of transdermal drug delivery – a non-invasive delivery of drugs via the skin. Over the last ten years, a growing number of analgesic drugs have become available as transdermal patches.
The transdermal drug delivery market has huge opportunities for growth, especially in the areas of dementia, paediatrics, generics and geriatrics. The USA is currently the most prominent market place, with Europe, Asia and emerging markets following in. The main factors driving the sector’s growth include patent expiries and the introduction of generic drugs, increased rates of compliance amid patients, increased burden of chronic diseases, and increased requirements for pediatric and geriatric drug administration, among others. However, the market is facing a range of challenges such as technical restraints, therapeutic failures and adverse drug reactions, amid others. The key opportunities emerging in the market place comprise high rates of collaboration between pharmacos and drug delivery companies, targeted drug delivery, a wider variety of disease states for transdermal administration, the bright future for the home health care market and OTC, etc.
Bayer, Actavis, GlaxoSmithKline, Novartis, Upsher-Smith, Ascend Therapeutics, Janssen Pharmaceuticals, ProStrakan, Noven Pharmaceuticals, Hercon Pharmaceutical, UCB, Shire, Endo International, 3M, Nitto Denko, Teikoku USA, and ParPharm, among others, are the dominant players in the market.
Cutting-edge report “Global Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation” worked out by Kelly Scientific Publications tackles the key problems that the global transdermal drug delivery market faces.
The study provides details about the economic and regulatory environment, including technologies driving the market, key most rapidly expanding market segments and emerging opportunities. A deep SWOT analysis is included, covering key market drivers and restraints, lucrative opportunities within the marketplace, as well as key barriers to entry. The report profiles the top pharma drug delivery, pharma and biotech companies in the market, discussing their product portfolios, research and development activities, pipeline products, M&As and prospective strategies. A wealth of financial and business strategy information is available, including companies’ actual financials, revenue and sales data, business model strategies.
Global Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation
Published: February, 2015
Price: US$ 3,400.00
More new studies by the publisher can be found at Kelly Scientific Publications page.